SciClone Pharmaceuticals (Holdings) Limited

SciClone Pharmaceuticals (Holdings) Limitedverified

6600.HK

Price:

$18.72

Market Cap:

$10.80B

SciClone Pharmaceuticals (Holdings) Limited, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products in the therapeutic areas of oncology and severe infection in Mainland China and internationally. The company's proprietary product is Zadaxin, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as an immune system enhance. Its in-licensed products include Zometa for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, and hypercalcemia of malignancy; DANYELZA for the treatment of relapsed/refractory high-risk neuroblastoma; an...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-03-03

Stock Exchange

HKSE

Ticker

6600.HK

The Current Ratio as of June 2025 (TTM) for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) is 4.94

According to SciClone Pharmaceuticals (Holdings) Limited’s latest financial reports and current stock price. The company's current Current Ratio is 4.94. This represents a change of 13.05% compared to the average of 4.37 of the last 4 quarters.

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Historical Current Ratio (quarterly & annually)

How has 6600.HK Current Ratio performed in the past?

The mean historical Current Ratio of SciClone Pharmaceuticals (Holdings) Limited over the last ten years is 2.58. The current 4.94 Current Ratio has changed 19.06% with respect to the historical average. Over the past ten years (40 quarters), 6600.HK's Current Ratio was at its highest in in the December 2019 quarter at 5.13. The Current Ratio was at its lowest in in the December 2020 quarter at 1.38.

Quarterly (TTM)
Annual

Average

2.58

Median

2.85

Minimum

0

Maximum

5.13

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SciClone Pharmaceuticals (Holdings) Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 5.13

Minimum Annual Increase = 0%

Minimum Annual Current Ratio = 0

Quarterly (TTM)
Annual
YearCurrent RatioChange
20234.9422.23%
20224.0428.85%
20213.13127.88%
20201.38-73.17%
20195.1311.84%
20184.5878.30%
20172.57Infinity%
201600%
201500%
201400%

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Average Current Ratio

How has 6600.HK Current Ratio performed in the past?

The current Current Ratio of SciClone Pharmaceuticals (Holdings) Limited (6600.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

4.04

5-year avg

3.72

10-year avg

2.58

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) Current Ratio vs. Peers

How is 6600.HK’s Current Ratio compared to its peers?

SciClone Pharmaceuticals (Holdings) Limited’s Current Ratio is less than New Horizon Health Limited (8.80), greater than Joinn Laboratories(China)Co.,Ltd. (4.61), less than Yidu Tech Inc. (6.85), greater than MicroPort CardioFlow Medtech Corporation (3.86), greater than Bairong Inc. (4.58),

Build a custom stock screener for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SciClone Pharmaceuticals (Holdings) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SciClone Pharmaceuticals (Holdings) Limited (6600.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SciClone Pharmaceuticals (Holdings) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is SciClone Pharmaceuticals (Holdings) Limited's Current Ratio?

How is the Current Ratio calculated for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

What is the highest Current Ratio for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

What is the 3-year average Current Ratio for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

What is the 5-year average Current Ratio for SciClone Pharmaceuticals (Holdings) Limited (6600.HK)?

How does the current Current Ratio for SciClone Pharmaceuticals (Holdings) Limited (6600.HK) compare to its historical average?